In another study of MCI and AD patients, while both female APOE4 heterozygotes and homozygotes showed increased tau deposition compared to female non-carriers, only male APOE4 homozygotes had increased tau deposition compared to male non-carriers [63]. The gene discussed is MAPT; the disease is Alzheimer disease.